HARVARD MANAGEMENT CO INC - Q4 2021 holdings

$1.07 Billion is the total value of HARVARD MANAGEMENT CO INC's 46 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 65.0% .

 Value Shares↓ Weighting
SGMS  SCIENTIFIC GAMES CORP$179,009,000
-19.5%
2,678,5710.0%16.80%
+28.8%
GOOGL SellALPHABET INCcap stk cl a$176,766,000
+8.3%
61,016
-0.1%
16.59%
+73.4%
RPRX SellROYALTY PHARMA PLC$138,080,000
-46.5%
3,464,990
-51.5%
12.96%
-14.3%
FB SellMETA PLATFORMS INCcl a$125,164,000
-48.3%
372,125
-47.8%
11.75%
-17.2%
ABCL  ABCELLERA BIOLOGICS INC$58,703,000
-28.6%
4,105,0950.0%5.51%
+14.3%
NewEQRX INC$35,888,0005,262,161
+100.0%
3.37%
TXG  10X GENOMICS INC$27,728,000
+2.3%
186,1430.0%2.60%
+63.9%
RXRX  RECURSION PHARMACEUTICALS INcl a$25,854,000
-25.6%
1,509,2540.0%2.43%
+19.3%
AFRM SellAFFIRM HLDGS INC$17,453,000
-80.6%
173,560
-77.0%
1.64%
-68.9%
RVMD  REVOLUTION MEDICINES INC$16,874,000
-8.5%
670,3820.0%1.58%
+46.5%
RLAY  RELAY THERAPEUTICS INC$16,618,000
-2.6%
541,1240.0%1.56%
+56.0%
PRAX  PRAXIS PRECISION MEDICINES I$15,337,000
+6.5%
778,5170.0%1.44%
+70.6%
NewGRAB HOLDINGS LIMITEDclass a ord$14,260,0002,000,000
+100.0%
1.34%
 TENAYA THERAPEUTICS INC$12,758,000
-8.2%
673,2700.0%1.20%
+46.9%
 ROCKET LAB USA INC$12,280,000
-23.9%
1,000,0000.0%1.15%
+22.0%
 MELI KASZEK PIONEER CORPclass a ord$11,560,000
+4.6%
1,000,0000.0%1.08%
+67.4%
PCT  PURECYCLE TECHNOLOGIES INC$10,236,000
-27.9%
1,069,6000.0%0.96%
+15.5%
CFLT NewCONFLUENT INC$9,940,000130,383
+100.0%
0.93%
MU NewMICRON TECHNOLOGY INC$9,565,000102,684
+100.0%
0.90%
NRIX  NURIX THERAPEUTICS INC$9,112,000
-3.4%
314,7620.0%0.86%
+54.6%
LRCX NewLAM RESEARCH CORP$9,004,00012,521
+100.0%
0.84%
KNTE  KINNATE BIOPHARMA INC$8,825,000
-23.0%
498,0010.0%0.83%
+23.2%
AMAT NewAPPLIED MATLS INC$7,955,00050,553
+100.0%
0.75%
AMD NewADVANCED MICRO DEVICES INC$7,858,00054,610
+100.0%
0.74%
INTC NewINTEL CORP$7,767,000150,806
+100.0%
0.73%
TSM NewTAIWAN SEMICONDUCTOR MFG LTDsponsored ads$7,753,00064,443
+100.0%
0.73%
 TANGO THERAPEUTICS INC$7,750,000
-15.4%
708,3850.0%0.73%
+35.4%
NVDA NewNVIDIA CORPORATION$7,740,00026,315
+100.0%
0.73%
PLRX  PLIANT THERAPEUTICS INC$7,592,000
-20.0%
562,3790.0%0.71%
+28.2%
ADI NewANALOG DEVICES INC$7,336,00041,739
+100.0%
0.69%
QRVO NewQORVO INC$7,345,00046,963
+100.0%
0.69%
FULC  FULCRUM THERAPEUTICS INC$7,266,000
-37.3%
410,7140.0%0.68%
+0.4%
SANA SellSANA BIOTECHNOLOGY INC$7,256,000
-72.3%
468,749
-59.7%
0.68%
-55.7%
ASML NewASML HOLDING N V$7,192,0009,034
+100.0%
0.68%
NewXILIO THERAPEUTICS INC$6,657,000416,059
+100.0%
0.62%
NewPARDES BIOSCIENCES INC$6,548,000400,000
+100.0%
0.62%
 SURROZEN INC$5,325,000
-9.0%
826,8520.0%0.50%
+45.8%
PACB  PACIFIC BIOSCIENCES CALIF IN$4,688,000
-19.9%
229,1440.0%0.44%
+28.3%
GBIO  GENERATION BIO CO$3,613,000
-71.8%
510,3540.0%0.34%
-54.8%
DBTX  DECIBEL THERAPEUTICS INC$1,529,000
-39.7%
328,7980.0%0.14%
-3.4%
MGTA  MAGENTA THERAPEUTICS INC$1,473,000
-39.2%
332,6100.0%0.14%
-2.8%
DYN  DYNE THERAPEUTICS INC$1,275,000
-26.8%
107,2520.0%0.12%
+17.6%
MCRB  SERES THERAPEUTICS INC$1,098,000
+19.6%
131,8470.0%0.10%
+90.7%
GMTX  GEMINI THERAPEUTICS INC$728,000
-27.9%
250,0000.0%0.07%
+15.3%
DADA NewDADA NEXUS LTDads$531,00040,338
+100.0%
0.05%
 SURROZEN INC*w exp 08/01/203$125,000
+0.8%
108,3330.0%0.01%
+71.4%
ExitAMPLITUDE CL A ORD (NMQ)class a ord$0-540
-100.0%
-0.00%
IJH ExitISHARES TRcore s&p mcp etf$0-12,683
-100.0%
-0.20%
VWO ExitVANGUARD INTL EQUITY INDEX Fftse emr mkt etf$0-73,804
-100.0%
-0.22%
FSII ExitFS DEVELOPMENT CORP II$0-400,000
-100.0%
-0.23%
IJR ExitISHARES TRcore s&p scp etf$0-49,559
-100.0%
-0.32%
VEA ExitVANGUARD TAX-MANAGED INTL FDftse dev mkt etf$0-162,699
-100.0%
-0.48%
GLD ExitSPDR GOLD TR$0-91,955
-100.0%
-0.88%
IVV ExitISHARES TRcore s&p500 etf$0-65,342
-100.0%
-1.65%
QQQ ExitINVESCO QQQ TRunit ser 1$0-101,448
-100.0%
-2.13%
AAPL ExitAPPLE INC$0-1,883,445
-100.0%
-15.62%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-02-11
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ISHARES TR34Q3 202119.4%
VANGUARD TAX-MANAGED INTL FD34Q3 202114.0%
VANGUARD INTL EQUITY INDEX F34Q3 202112.2%
SPDR GOLD TRUST34Q3 20218.7%
ISHARES TR34Q3 20214.9%
META PLATFORMS INC29Q3 202337.6%
VANGUARD SPECIALIZED PORTFOL28Q1 20202.8%
MAGENTA THERAPEUTICS INC21Q2 20231.4%
ALPHABET INC19Q3 202330.4%
ISHARES TR19Q3 20214.4%

View HARVARD MANAGEMENT CO INC's complete holdings history.

Latest significant ownerships (13-D/G)

View HARVARD MANAGEMENT CO INC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-09
13F-HR2023-11-09
13F-HR2023-08-11
13F-HR2023-05-15
13F-HR2023-02-10
13F-HR2022-11-10
13F-HR2022-08-12
13F-HR2022-05-13
13F-HR2022-02-11
13F-HR2021-11-12

View HARVARD MANAGEMENT CO INC's complete filings history.

Compare quarters

Export HARVARD MANAGEMENT CO INC's holdings